Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Surmodics Inc SRDX

Healthcare Medical Devices
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve... see more

Recent & Breaking News (NDAQ:SRDX)

Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance

Business Wire May 2, 2018

Detailed Research: Economic Perspectives on Vitamin Shoppe, Surmodics, Spark Therapeutics, QUANTENNA COMMS, Westinghouse Air Brake Technologies, and Resource Capital — What Drives Growth in Today's Competitive Landscape

GlobeNewswire May 1, 2018

Surmodics to Webcast Second Quarter Fiscal 2018 Earnings Conference Call on May 2

Business Wire April 24, 2018

Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter

Business Wire April 23, 2018

Research Report Identifies Alamo Group, Surmodics, Nicolet Bankshares, Carriage Services, Terra Nitrogen Company, and Waterstone Financial with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

GlobeNewswire March 22, 2018

Surmodics to Present at Upcoming Investor Conferences

Business Wire March 15, 2018

Mid-Morning Market Update: Markets Mostly Higher; Ciena Profit Tops Expectations

Benzinga.com  March 6, 2018

35 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  February 27, 2018

Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon

PR Newswire February 27, 2018

Surmodics to Host Virtual Annual Meeting of Shareholders

Business Wire February 13, 2018

Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance

Business Wire February 8, 2018

Surmodics to Webcast First Quarter Fiscal 2018 Earnings Conference Call on February 8

Business Wire January 30, 2018

Surmodics Receives 510(K) Clearance for Telemark™ Coronary/Peripheral Support Microcatheter from the U.S. Food and Drug Administration

Business Wire January 22, 2018

Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance

Business Wire November 8, 2017

Surmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics Forum

Business Wire October 26, 2017

Surmodics to Webcast Fourth Quarter 2017 Earnings Conference Call on November 8

Business Wire October 26, 2017

Surmodics Announces First Patient Enrolled in TRANSCEND Pivotal Clinical Trial for SurVeil® Drug-Coated Balloon

Business Wire October 23, 2017

Surmodics Announces Global Approvals of .014" Low-Profile PTA Balloon Dilation Catheter

Business Wire September 18, 2017

Six-Month Data from the Surmodics SurVeil® Drug-Coated Balloon Early Feasibility Study Presented at VIVA 2017

Business Wire September 13, 2017

Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance

Business Wire August 3, 2017